INmune Bio Inc logo

INmune Bio Inc

NAS:INMB (USA)  
$ 12.92 +0.255 (+2.01%) 10:08 PM EST
At Loss
P/B:
5.21
Market Cap:
$ 232.84M
Enterprise V:
$ 203.94M
Volume:
40.81K
Avg Vol (2M):
81.65K
Volume:
40.81K
At Loss
Avg Vol (2M):
81.65K

Business Description

Description
INmune Bio Inc is a clinical-stage biotechnology company. It is engaged in the development of new immunotherapies that reprogram a patient's innate immune system to allow immune system to fight cancer. The company's pipeline products includeINKmune, INBO3, XPro1595, LIVNate, and others.
Name Current Vs Industry Vs History
Cash-To-Debt 3.24
Equity-to-Asset 0.71
Debt-to-Equity 0.29
Debt-to-EBITDA -0.48
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.42
Distress
Grey
Safe
Beneish M-Score -3.99
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 50.29
9-Day RSI 53.14
14-Day RSI 54.15
6-1 Month Momentum % 35
12-1 Month Momentum % 17.14

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.18
Quick Ratio 3.18
Cash Ratio 2.91

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -18.6
Shareholder Yield % 0.24

Financials (Next Earnings Date:2024-03-01 Est.)

INMB's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:INMB

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

INmune Bio Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 0.224
EPS (TTM) ($) -1.52
Beta 1.18
Volatility % 58.36
14-Day RSI 54.15
14-Day ATR ($) 1.021246
20-Day SMA ($) 12.4915
12-1 Month Momentum % 17.14
52-Week Range ($) 5.87 - 14.74
Shares Outstanding (Mil) 18

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

INmune Bio Inc Filings

Filing Date Document Date Form
No Filing Data

INmune Bio Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

INmune Bio Inc Frequently Asked Questions

What is INmune Bio Inc(INMB)'s stock price today?
The current price of INMB is $12.92. The 52 week high of INMB is $14.74 and 52 week low is $5.87.
When is next earnings date of INmune Bio Inc(INMB)?
The next earnings date of INmune Bio Inc(INMB) is 2024-03-01 Est..
Does INmune Bio Inc(INMB) pay dividends? If so, how much?
INmune Bio Inc(INMB) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1